In the US regulatory system, generally there's no requirement to keep with the State of the Art. If by "commercialised" you mean that a device model has already been cleared (eg 510(k)) and legally sold in the US, no further edition upgrades are required as long as the design is not changed (unless a specific requirement has been issued by the FDA). Only submissions occurring after the switch over date are required to meet the new edition.